P. Dandekar, P. Tessier, and P. Williams, Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection model, Journal of Antimicrobial Chemotherapy, vol.52, issue.3, pp.405-416, 2003.
DOI : 10.1093/jac/dkg337

J. Yu, J. Wu, and K. Francis, Monitoring in vivo fitness of rifampicin-resistant Staphylococcus aureus mutants in a mouse biofilm infection model, Journal of Antimicrobial Chemotherapy, vol.55, issue.4, pp.528-562, 2005.
DOI : 10.1093/jac/dki053

W. Hengzhuang, H. Wu, and O. Ciofu, In Vivo Pharmacokinetics/Pharmacodynamics of Colistin and Imipenem in Pseudomonas aeruginosa Biofilm Infection, Antimicrobial Agents and Chemotherapy, vol.56, issue.5, pp.2683-90, 2012.
DOI : 10.1128/AAC.06486-11

D. Abbanat, W. Shang, and K. Amsler, Evaluation of the in vitro activities of ceftobiprole and comparators in staphylococcal colony or microtitre plate biofilm assays, International Journal of Antimicrobial Agents, vol.43, issue.1, pp.32-41, 2014.
DOI : 10.1016/j.ijantimicag.2013.09.013

N. Hoiby, T. Bjarnsholt, and C. Moser, ESCMID??? guideline for the diagnosis and treatment of biofilm infections 2014, Clinical Microbiology and Infection, vol.21, issue.1, pp.1-25, 2015.
DOI : 10.1016/j.cmi.2014.10.024

O. Lyons, A. Patel, and P. Saha, A 14-year Experience with Aortic Endograft Infection: Management and??Results, European Journal of Vascular and Endovascular Surgery, vol.46, issue.3, pp.306-319, 2013.
DOI : 10.1016/j.ejvs.2013.04.021

S. Tong, J. Davis, and E. Eichenberger, Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management, Clinical Microbiology Reviews, vol.28, issue.3, pp.603-61, 2015.
DOI : 10.1128/CMR.00134-14

M. Maze, P. Laws, and T. Buckenham, Outcomes of infected abdominal aortic grafts managed with antimicrobial therapy and graft retention in an unselected cohort

S. Erb, J. Sidler, and L. Elzi, Surgical and Antimicrobial Treatment of Prosthetic Vascular Graft Infections at Different Surgical Sites: A Retrospective Study of Treatment Outcomes, PLoS ONE, vol.86, issue.11, pp.112947-112974, 2014.
DOI : 10.1371/journal.pone.0112947.t003

L. Legout, B. Sarraz-bournet, D. Elia, and P. , Characteristics and prognosis in patients with prosthetic vascular graft infection: a prospective observational cohort study, Clinical Microbiology and Infection, vol.18, issue.4, pp.352-360, 2012.
DOI : 10.1111/j.1469-0691.2011.03618.x

A. Giacometti, O. Cirioni, and R. Ghiselli, Temporin A Soaking in Combination with Intraperitoneal Linezolid Prevents Vascular Graft Infection in a Subcutaneous Rat Pouch Model of Infection with Staphylococcus epidermidis with Intermediate Resistance to Glycopeptides, Antimicrobial Agents and Chemotherapy, vol.48, issue.8, pp.3162-3166, 2004.
DOI : 10.1128/AAC.48.8.3162-3164.2004

H. Turgut, S. Sacar, and I. Kaleli, Systemic and local antibiotic prophylaxis in the prevention of Staphylococcus epidermidisgraft infection, BMC Infectious Diseases, vol.15, issue.4, pp.91-121, 2005.
DOI : 10.1007/s100160010051

E. Atahan, M. Gul, and Y. Ergun, Vascular Graft Infection by Staphylococcus aureus: Efficacy of Cefazolin, Teicoplanin and Vancomycin Prophylaxis Protocols in a Rat Model, European Journal of Vascular and Endovascular Surgery, vol.34, issue.2
DOI : 10.1016/j.ejvs.2007.03.002

A. Oliva, F. Tafin, U. Maiolo, and E. , Activities of Fosfomycin and Rifampin on Planktonic and Adherent Enterococcus faecalis Strains in an Experimental Foreign-Body Infection Model, Antimicrobial Agents and Chemotherapy, vol.58, issue.3, pp.1284-93, 2014.
DOI : 10.1128/AAC.02583-12

F. Tafin, U. Majic, I. , Z. Belkhodja, and C. , Gentamicin Improves the Activities of Daptomycin and Vancomycin against Enterococcus faecalis In Vitro and in an Experimental Foreign-Body Infection Model, Antimicrobial Agents and Chemotherapy, vol.55, issue.10, pp.4821-4828, 2011.
DOI : 10.1128/AAC.00141-11

F. Tafin, U. Corvec, S. Betrisey, and B. , Role of Rifampin against Propionibacterium acnes Biofilm In Vitro and in an Experimental Foreign-Body Infection Model, Antimicrobial Agents and Chemotherapy, vol.56, issue.4, pp.1885-91, 2012.
DOI : 10.1128/AAC.05552-11

W. Zimmerli, F. Waldvogel, and P. Vaudaux, Pathogenesis of Foreign Body Infection: Description and Characteristics of an Animal Model, Journal of Infectious Diseases, vol.146, issue.4, pp.487-97, 1982.
DOI : 10.1093/infdis/146.4.487

S. Schwank, Z. Rajacic, and W. Zimmerli, Impact of bacterial biofilm formation on in vitro and in vivo activities of antibiotics, Antimicrob Agents Chemother, vol.42, pp.895-903, 1998.

K. Shimabukuro, H. Hirose, and Y. Mori, Local treatment of Dacron patch graft infected with biofilm-producing Staphylococcus epidermidis using antibiotic-releasing porous apatite ceramic: an experimental study in the rabbit, Journal of Vascular Surgery, vol.39, issue.6, pp.1361-1398, 2004.
DOI : 10.1016/j.jvs.2004.03.004

L. Jones, B. Braithwaite, and B. Davies, Mechanism of late prosthetic vascular graft infection, Cardiovascular Surgery, vol.5, issue.5, pp.486-495, 1997.
DOI : 10.1016/S0967-2109(97)00056-2

R. Boudjemaa, R. Briandet, and M. Fontaine-aupart, Bioavailability and Reactivity of Antibiotics against Staphylococcus aureus Biofilms: a New Approach by Dynamic Fluorescence Imaging, International Conference on Antimicrobial Agents and Chemotherapy, p.1415, 2014.

C. Edmiston, J. Goheen, M. Seabrook, and G. , Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices, The American Journal of Surgery, vol.192, issue.3, pp.344-54, 2006.
DOI : 10.1016/j.amjsurg.2006.04.009

O. Murillo, C. Garrigos, and M. Pachon, Efficacy of High Doses of Daptomycin versus Alternative Therapies against Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus, Antimicrobial Agents and Chemotherapy, vol.53, issue.10, pp.4252-4259, 2009.
DOI : 10.1128/AAC.00208-09

C. Garrigos, O. Murillo, and G. Euba, Efficacy of Usual and High Doses of Daptomycin in Combination with Rifampin versus Alternative Therapies in Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus, Antimicrobial Agents and Chemotherapy, vol.54, issue.12, pp.5251-642, 2010.
DOI : 10.1128/AAC.00226-10

P. Stewart, W. Davison, and J. Steenbergen, Daptomycin Rapidly Penetrates a Staphylococcus epidermidis Biofilm, Antimicrobial Agents and Chemotherapy, vol.53, issue.8, pp.3505-3512, 2009.
DOI : 10.1128/AAC.01728-08

K. Smith, A. Perez, and G. Ramage, Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin, International Journal of Antimicrobial Agents, vol.33, issue.4, pp.374-382, 2009.
DOI : 10.1016/j.ijantimicag.2008.08.029

M. Lefebvre, J. C. Amador, and G. , Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis, International Journal of Antimicrobial Agents, vol.36, issue.6, pp.542-546, 2010.
DOI : 10.1016/j.ijantimicag.2010.07.008

E. Senneville, D. Joulie, and L. Legout, Outcome and Predictors of Treatment Failure in Total Hip/Knee Prosthetic Joint Infections Due to Staphylococcus aureus, Clinical Infectious Diseases, vol.53, issue.4, pp.334-374, 2011.
DOI : 10.1093/cid/cir402

G. Sakoulas, G. Eliopoulos, and J. Alder, Efficacy of Daptomycin in Experimental Endocarditis Due to Methicillin-Resistant Staphylococcusaureus, Antimicrobial Agents and Chemotherapy, vol.47, issue.5, pp.1714-1722, 2003.
DOI : 10.1128/AAC.47.5.1714-1718.2003

A. Saleh-mghir, C. Muller-serieys, and A. Dinh, Adjunctive Rifampin Is Crucial to Optimizing Daptomycin Efficacy against Rabbit Prosthetic Joint Infection Due to Methicillin-Resistant Staphylococcus aureus, Antimicrobial Agents and Chemotherapy, vol.55, issue.10, pp.4589-93, 2011.
DOI : 10.1128/AAC.00675-11

W. Rose, S. Leonard, and M. Rybak, Evaluation of Daptomycin Pharmacodynamics and Resistance at Various Dosage Regimens against Staphylococcus aureus Isolates with Reduced Susceptibilities to Daptomycin in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations, Antimicrobial Agents and Chemotherapy, vol.52, issue.9, pp.3061-3068, 2008.
DOI : 10.1128/AAC.00102-08

J. Miro, C. Garcia-de-la-maria, and Y. Armero, Addition of Gentamicin or Rifampin Does Not Enhance the Effectiveness of Daptomycin in Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus, Antimicrobial Agents and Chemotherapy, vol.53, issue.10, pp.4172-4179, 2009.
DOI : 10.1128/AAC.00051-09

C. Garrigos, O. Murillo, and J. Lora-tamayo, Efficacy of Daptomycin-Cloxacillin Combination in Experimental Foreign-Body Infection Due to Methicillin-Resistant Staphylococcus aureus, Antimicrobial Agents and Chemotherapy, vol.56, issue.7, pp.3806-3817, 2012.
DOI : 10.1128/AAC.00127-12